Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III Randomized, Double-Blind, Active-Comparator Controlled Clinical Trial to Study the Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4, and 12 Months (V419-007-03)

Next Previous
Trial Profile

A Phase III Randomized, Double-Blind, Active-Comparator Controlled Clinical Trial to Study the Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4, and 12 Months (V419-007-03)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 11 May 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hib-DTaP-hepatitis B-poliovirus vaccine (Primary) ; Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa); MMR-varicella zoster virus vaccine; Pneumococcal 13-valent CRM197 vaccine conjugate; Rotavirus W179-9 vaccine
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors MCM Vaccine; sanofi pasteur MSD

Most Recent Events

  • 01 Feb 2021 Results from protocol 005,006,007,008 and 011 assessing protective immune responses of DTaP-IPV-Hib-HepB vaccine against Haemophilus influenza type B, published in the Vaccine
  • 21 Mar 2019 Data from 6 studies (Protocols 004, 005, 006, 007, 008, and PRI01C) were integrated and analyzed to provide a comprehensive safety profile, results published in the Pediatric Infectious Disease Journal
  • 27 Nov 2018 Result analysis from NCT00362427, NCT01337167, NCT01340937, NCT01341639, NCT01480258, NCT01553279, providing a comprehensive safety profile, published in the Pediatric Infectious Disease Journal.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top